Clinical Trial Update: PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a PD-1 antibody in combination with a COX inhibitor for MSI-H/dMMR or high tumor mutational burden colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• COX inhibitor
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN